查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827864

互聯醫療設備市場（按產品類型、應用、最終用戶、連接技術和分銷管道分類）—2025-2032 年全球預測

Connected Medical Devices Market by Product Type, Application, End User, Connectivity Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，連網醫療設備市場將成長至 2,913.7 億美元，複合年成長率為 23.24%。

主要市場統計數據
基準年2024年 547.5億美元
預計2025年 672.6億美元
預測年份：2032年 2913.7億美元
複合年成長率（%） 23.24%

整合感測、分析和連結如何改變臨床工作流程、產品設計優先順序和上市動態的策略概述

互聯醫療設備正在重塑醫療服務，它融合了感測、分析和連接技術，將臨床監測擴展到傳統醫療環境之外。這種硬體、軟體和雲端服務的整合正在催生持續監測模式，從而開闢新的護理途徑，實現早期發現和干涉，減少住院時間，並改善慢性病管理。因此，設備製造商、數位醫療公司和醫療服務提供者必須將產品開發與臨床工作流程、互通性標準和網路安全態勢同步。

在整個生態系統中，創新不再只涉及組件的改進，而需要系統思維來協調使用者體驗、法規遵循和資料生命週期管理。隨著連網型設備的臨床和商業性價值不斷提升，組織必須面臨複雜的權衡：如何在設備小型化和電池壽命與數據保真度之間取得平衡，如何將軟體功能發布的節奏與證據生成同步，以及如何協調將設備銷售與持續性服務相結合的收益模式。有效的應對措施需要工程、臨床、監管和商業團隊之間的跨職能協作。

相關人員也在不斷變化的政策和貿易環境中運作，這可能會影響採購、製造和分銷決策。總而言之，這些動態既為大規模提供差異化患者治療方案的能力創造了機遇，也帶來了風險，同時也帶來了供應鏈中斷、網路威​​脅和報銷不確定性。本介紹將透過識別組織必須應對的策略曲折點，為後續的綜合分析奠定基礎，以便從互聯醫療設備中獲取長期價值。

加速軟體成熟度、先進的連接標準和不斷變化的報銷模式如何重新定義競爭優勢和監管義務

互聯醫療設備領域正在經歷一系列變革，這些變革時期正在重新定義競爭優勢、監管預期和醫療服務交付模式。首先，嵌入式軟體和人工智慧主導分析的成熟度曲線正從原型實驗階段轉向臨床可行能力，這迫使製造商採用生命週期方法進行軟體檢驗、上市後效能監控和演算法管治。因此，產品藍圖現在將臨床證據生成和可解釋性作為核心商業需求，而非可選功能。

其次，低功率廣域網路和高吞吐量行動電話標準的普及正在擴大遠端監控和遠端醫療整合的覆蓋範圍。這種連接性的演進使設備能夠在分散式護理模式下運行，比前幾代設備具有更低的延遲、更豐富的遠端檢測和更高的可靠性。這也強化了句法和語義互通性的重要性，以便患者資料能夠在不同的醫療IT系統之間進行聚合、標準化和利用。

第三，報銷和採購實踐正逐步適應基於價值的模式，為那些能夠顯著降低急性病護理利用率並改善慢性病治療效果的設備提供獎勵。同時，監管機構正在完善關於軟體作為醫療設備、網路安全風險管理和真實世界效能證據的指導，迫使製造商將監管策略整合到其產品開發週期中。

最後，隨著設備製造商、雲端服務供應商和臨床網路之間策略聯盟的蓬勃發展，市場結構也在改變。這些聯盟加速了市場進入，但也帶來了新的依賴關係和責任共用。這種轉變的最終結果是，市場競爭格局的形成取決於臨床檢驗、連結整合和上市後管理方面的敏捷性，從而區分市場領導者和後進企業。

關稅對聯網醫療設備相關人員的採購、產品設計和供應鏈彈性的營運和策略影響

近期針對醫療設備投入品和成品的貿易行動，給製造商和供應商帶來了複雜的成本、採購和調度壓力。關稅加上互惠貿易回應，正在改變零件和組裝的原產地計算方式，促使企業重新評估其供應商組合，增加庫存緩衝，並加速近岸外包和雙重採購策略。這些調整對下游領域也產生了影響，包括前置作業時間、品管流程以及用於製造升級的資本配置。

從商業角度來看，某些零件的關稅上調可能會增加設備的實際到岸成本，除非透過價格調整、降低供應商成本或轉向替代材料來抵消，否則可能會壓縮淨利率。面臨關稅影響的製造商通常會進行重新設計，以從其他司法管轄區採購的功能等效的替代品來取代受關稅影響的零件。此類重新設計通常涉及更新的合格測試和監管備案，從而導致時間安排超出當前商業週期。

應對關稅環境的策略性舉措各不相同。一些組織選擇在優惠的關稅管轄區內整合高價值組件，而另一些組織則透過服務合約或管理式醫療安排來建立價格彈性，從而轉移部分成本負擔。同時，採購團隊強調在關稅上漲的情況下保留重新談判權利的合約條款，並鼓勵簽訂長期供應協議以確保產能。

重要的是，關稅也會影響創新軌跡。如果零件成本上升，開發重點可能會轉向利潤率更高的設備、軟體驅動的服務層或受跨境關稅影響較小的售後市場耗材。同時，圍繞貿易措施的政策不確定性提升了情境規劃和產品系列壓力測試的價值，使企業能夠在其他關稅軌跡下保持業務連續性和市場進入。

詳細的細分分析將產品子類、臨床用途、最終用戶環境、連接方式和分銷管道與採用槓桿聯繫起來

細粒度的細分揭示了產品設計、臨床使用、最終用戶環境、連接選項和分銷策略如何影響採用動態和商業性優先順序。按產品類型（診斷、監測、手術、治療和穿戴式裝置）細分市場反映了臨床醫生和患者的細微需求。診斷設備，特別是成像系統、就地檢驗套件和超音波系統，需要高診斷準確性、強大的校準工作流程以及與影像歸檔和通訊系統的互通性。監測設備（例如心電圖監測儀、血糖監測儀和生命徵象監測儀）優先考慮持續性資料完整性、電源管理和警報管理，以支援臨床決策。手術設備（例如電外科設備、內視鏡設備和機器人手術系統）需要嚴格的可靠性、無菌相容性以及與手術室資訊學的無縫整合。治療設備（例如透析系統、輸液幫浦和人工呼吸器）優先考慮安全冗餘、劑量準確性和故障安全機制。健身追蹤器和智慧型手錶等穿戴式裝置平衡了消費者人體工學、感測器保真度和無縫行動連線，以鼓勵持續使用。

基於應用的細分進一步明確了藥物傳輸、診斷影像、病患監測、復健、手術輔助和遠端醫療的價值提案。在藥物傳遞方面，輸液給藥、吸入系統和注射給藥之間的差異會影響設備外形規格、依從性監測以及與電子藥歷的連接性。 CT、MRI、超音波影像影像和X光等診斷影像方式分別涉及不同的監管途徑、資本密集度和臨床醫師訓練需求。病患監測包括門診監測、重症患者監測和遠端監測，每種方式都有不同的訊號擷取優先順序、延遲接受度以及與臨床工作流程的整合需求。從神經復健到職業治療和物理治療的復健應用利用感測器和回饋迴路來量化結果並支持遠距照護。導航系統和機器人手術輔助強調精密動態、即時影像處理和外科醫生介面設計的整合。在遠端醫療領域，遠距離診斷、遠端患者監護和視訊諮詢等子領域強調了無縫、安全的資料交換和清晰的升級路徑的必要性。

最終使用者群體（例如門診護理中心、診所、診斷中心、居家照護機構和醫院）決定了採購週期和支援要求。居家照護機構（包括老年護理和術後護理）優先考慮易用性、看護者支援和遠端臨床醫生監控。公立和私立醫院都需要規模、服務水準協議以及臨床和經濟效益證據來支持資本投資。連接技術的選擇——藍牙（包括 BLE 和傳統藍牙）、從 2G 到 5G 的蜂窩標準、NFC、Wi-Fi（802.11ac 和 802.11n）和 Zigbee——決定了設備的互通性、通訊、範圍和安全架構。最後，線下和線上通路之間的差異會影響客戶體驗、安裝服務和售後支援。雖然線上管道加速了初始採購，但線下管道對於複雜的設備安裝和培訓通常至關重要。

影響美洲、歐洲、中東和非洲以及亞太市場商業化、監管策略和供應鏈選擇的區域考量

區域動態顯著影響互聯醫療設備的需求促進因素、監管要求和上市執行。在美洲，成熟的報銷體系、先進的醫院基礎設施以及對遠端監控的強烈需求，共同支撐了那些在降低急性護理利用率方面展現出顯著價值的設備。該地區還擁有強大的私人和公共支付機構網路，這有望加速慢性病管理和急性後期護理中設備的普及。同時，供應鏈物流和與零件供應商的接近性使美洲成為近岸外包和快速產品迭代的中心。

歐洲、中東和非洲是一個多元化的環境，監管協調工作和多樣化的採購模式並存。許多歐洲市場需要透過集中採購和醫療技術評估流程獲得強力的臨床和經濟證據，而中東和非洲市場預計將在私人醫院擴張和數位醫療基礎設施投資的推動下實現高速成長。在全部區域，資料保護標準和互通性工作影響設備設計和雲端架構的決策，因此需要製定適應性監管策略和針對特定地區的支援模式。

亞太地區涵蓋了廣泛的成熟度水平，從擁有強大國內製造生態系統的已開發市場，到正在透過數位優先部署超越傳統基礎設施的快速發展的醫療保健系統。該地區的規模和多樣性為可擴展、低成本的設備變體和模組化平台創造了機會，這些平台可以根據本地臨床需求進行客製化。此外，委託製造和電子產品供應商的豐富資源支援成本最佳化策略，而不斷發展的報銷框架和龐大的患者群體為遠端監控和遠端醫療解決方案提供了肥沃的土壤。總而言之，區域洞察凸顯了差異化商業化策略的必要性，這些策略應將證據生成、供應鏈設計和夥伴關係生態系統與本地市場實際情況相結合。

分析現有企業和挑戰者的策略，強調平台化、夥伴關係和以證據主導的商業化，以擴大連網設備供應

互聯醫療設備領域的主要企業展現出一致的模式，即將軟體和服務整合到其核心產品中，優先考慮網路安全和法規遵從性，並建立生態系統夥伴關係以擴大臨床覆蓋範圍。市場領先的公司投資模組化平台，以實現快速功能部署和第三方整合，同時保持嚴格的軟體更新和上市後監測變更控制流程。他們的研發方法強調臨床協作、與醫療系統的試點部署以及迭代檢驗，以建立臨床醫生的信任和報銷途徑。

規模較小的公司通常專注於利基臨床問題，並利用敏捷性來迭代使用者介面，從而加快上市時間。這些公司通常尋求與雲端和分析提供者合作，以補充其內部能力，並與通路經銷商和醫療系統合作，以獲得初步規模。許多此類公司採用混合經營模式，將設備銷售與分析訂閱、遠端監控服務和耗材的經常性收益相結合。

縱觀競爭格局，我們看到傳統設備製造商與數位健康專家之間的策略聯盟日益增加。這些聯盟加速了資料科學能力、病人參與工具和人口健康管理平台的取得。同時，非傳統參與企業優先考慮速度和體驗設計，但必須快速開發臨床檢驗流程和監管專業知識，以保持永續的競爭優勢。總而言之，這些公司層面的行動凸顯了整合臨床證據、強大的網路安全和夥伴關係主導的分銷管道，在複雜的醫療環境中有效擴展規模的競爭必要性。

製造商和供應商應採取實際的策略舉措，以增強產品開發、供應鏈彈性以及連網型設備的上市模式

為了從互聯醫療設備中獲取長期價值，產業領導者應採取三管齊下的方法，將產品策略、營運韌性和上市計畫協調一致。首先，在產品開發早期就納入監管和臨床證據規劃，以推動軟體迭代、演算法更新和硬體修訂，同時最大限度地減少下游摩擦。主動規劃可以加快新功能的上市時間，並在結果數據可用時增強與付款人的對話。

其次，重新設計您的供應鏈和籌資策略，以增強抵禦貿易中斷和關稅帶來的成本壓力的能力。這包括實現零件供應商多元化，在可行的情況下篩選合格的替代材料，並評估關鍵組件的近岸外包。同時，調整您的採購契約，納入關稅轉嫁的靈活條款，並為面臨波動性貿易風險的關鍵零件建立策略性庫存緩衝。

第三，我們將優先考慮互通性、網路安全和以使用者為中心的設計，以加速醫療機構的採用。我們將投資開放API、基於標準的資料模型和嚴格的採用測試，同時進行以臨床醫生為中心的可用性研究，以最大限度地減少培訓負擔。同時，我們將開發一種將設備銷售與訂閱服務結合的商業模式，以較低的前期成本為客戶提供可預測的收益。

最後，我們與付款人、醫療系統和技術提供者建立策略夥伴關係，共同開發報銷途徑和綜合護理計劃。我們進行試點部署，收集現實世界證據，以支持報銷談判並擴大臨床適應症。透過實施這些建議，企業可以降低營運風險，提高產品與市場的契合度，並將連網型設備的力量轉化為永續的商業性優勢。

我們的透明研究途徑結合了相關人員訪談、技術評估、監管審查和情境測試，以檢驗連網型設備洞察。

支撐本分析的研究綜合了主要相關人員訪談、技術產品評估、政策和監管審查以及二手文獻整合，旨在提供對互聯醫療設備格局的整體視角。主要輸入包括與臨床醫生、採購負責人、監管專家和設備工程師進行的結構化訪談，以根據營運現狀和證據需求提供見解。這些訪談也輔以對代表性設備架構、連接堆疊和網路安全態勢的技術評估，以突顯反覆出現的工程約束和整合模式。

監管和政策審查流程考察了目前關於軟體作為醫療設備的指導、網路安全要求以及影響醫療技術供應鏈的貿易措施。審查還結合了區域採購機制和報銷框架的比較分析，以評估證據閾值和購買行為在不同市場之間的差異。我們也進行了二手文獻和上市公司分析，以檢驗公司策略並分析產業趨勢，並運用成功的試點案例來闡述規模化發展路徑。

此分析方法將定性主題編碼與基於情境的壓力測試相結合，以評估對資費變化、連接性變化和監管更新的敏感性。在適用的情況下，我們採用證據層級結構來衡量臨床研究、試驗結果和實際表現數據。在整個過程中，我們始終保持假設和資料來源的透明度，以確保可複製性，並支持客戶後續問題，從而更深入地了解特定產品和區域的細微差別。

將聯網醫療設備創新轉化為持續臨床價值和商業性成功的系統性要求的總結性觀點

互聯醫療設備代表著醫療保健轉型的關鍵前沿，為更早診斷、持續慢性病管理以及更有效率地利用臨床資源提供了途徑。先進感測技術、嵌入式軟體和無所不在的連接技術的融合，正在推動人們對產品設計、證據產生和上市後管理的全新期望。能夠將臨床檢驗、網路安全和互通性與彈性供應鏈同步的組織，將佔據有利地位，從而擴大市場規模並保持市場優勢。

但未來之路充滿挑戰。關稅和貿易不確定性迫使企業重新評估籌資策略和成本結構，而不斷變化的監管和報銷格局則要求嚴謹的證據規劃。市場領導者正透過產品平台化、建立策略夥伴關係以及投資於支持臨床醫生採用和付款人覆蓋的真實世界性能證據來應對挑戰。成功的關鍵在於採取一種綜合方法，將產品開發、營運和上市流程與可衡量的臨床和經濟成果相結合。

最後，將互聯設備視為系統，並共同設計硬體、軟體、臨床工作流程和商業模式的醫療保健機構將釋放最大的價值。那些對供應鏈和監管途徑實施嚴格風險管理，同時持續關注用戶需求和數據品質的機構，將能夠將技術可能性轉化為持久的臨床影響。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 在聯網醫療設備中實施端對端加密通訊協定，以增強網路安全
  • 整合人工智慧演算法，即時分析患者產生的健康數據流
  • 採用標準化的互通性框架，實現跨醫療平台的無縫資料交換
  • 在醫療設備內部署邊緣運算架構，以減少延遲並提高治療回應能力
  • 開發電池最佳化技術以延長無線醫療監測設備的使用壽命
  • 將語音控制和自然語言處理整合到醫療設備介面以提高可訪問性

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 連網醫療設備市場（依產品類型）

  • 診斷設備
    • 影像系統
    • 就地檢驗套件
    • 超音波設備
  • 監控設備
    • 心電圖監測儀
    • 血糖值監測儀
    • 生命徵象監測儀
  • 手術設備
    • 電外科設備
    • 內視鏡設備
    • 機器人手術系統
  • 治療設備
    • 透析系統
    • 點滴幫浦
    • 人工呼吸器
  • 穿戴式裝置
    • 健身追蹤器
    • 智慧型手錶

9. 網路醫療設備市場（按應用）

  • 藥物輸送
    • 靜脈給藥
    • 吸入系統
    • 注射藥物輸送
  • 影像學
    • CT
    • MRI
    • 超音波影像
    • X光
  • 病患監測
    • 門診監護
    • 加護治療監測
    • 遠端監控
  • 復原
    • 神經復健
    • 職能治療
    • 物理治療
  • 手術援助
    • 導航系統
    • 機器人協助
  • 遠端醫療
    • 遠距離診斷
    • 遠端患者監護
    • 視訊諮詢

第 10 章：連網醫療設備市場（按最終用戶分類）

  • 門診治療中心
  • 診所
  • 診斷中心
  • 居家照護環境
    • 老年護理
    • 術後護理
  • 醫院
    • 私立醫院
    • 公立醫院

第 11 章：按連接技術分類的連接醫療設備市場

  • Bluetooth
    • BLE
    • 經典藍牙
  • 蜂巢
    • 2G 3G 4G
    • 5G
  • NFC
  • Wi-Fi
    • 802 11ac
    • 802 11n
  • ZigBee

第 12 章 互聯醫療設備市場（依分銷管道）

  • 離線
  • 線上

第 13 章：按地區分類的連網醫療設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 聯網醫療設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章：各國連網醫療設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Koninklijke Philips NV
    • General Electric Company
    • Medtronic plc
    • Siemens Healthineers AG
    • Johnson & Johnson
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Baxter International Inc.
    • ResMed Inc.
    • Dexcom, Inc.
Product Code: MRR-43750BE226AB

The Connected Medical Devices Market is projected to grow by USD 291.37 billion at a CAGR of 23.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 54.75 billion
Estimated Year [2025] USD 67.26 billion
Forecast Year [2032] USD 291.37 billion
CAGR (%) 23.24%

A strategic overview of how integrated sensing, analytics, and connectivity are transforming clinical workflows, product design priorities, and market entry dynamics

Connected medical devices are reshaping care delivery by integrating sensing, analytics, and connectivity to extend clinical oversight beyond traditional care settings. This convergence of hardware, software, and cloud-enabled services has cultivated new care pathways, enabled earlier detection and intervention, and fostered continuous monitoring models that reduce hospital stays and improve chronic disease management. The result is a landscape in which device manufacturers, digital health companies, and care providers must synchronize product development with clinical workflows, interoperability standards, and cybersecurity postures.

Across the ecosystem, innovation is no longer confined to component improvements; it now requires systems thinking that aligns user experience, regulatory compliance, and data lifecycle management. As the clinical and commercial value of connected devices increases, organizations must confront complex trade-offs: balancing device miniaturization and battery longevity against data fidelity; reconciling the pace of software feature releases with evidence generation; and harmonizing revenue models that mix device sales with recurring services. Effective responses demand cross-functional collaboration among engineering, clinical, regulatory, and commercial teams.

Stakeholders also operate within an evolving policy and trade environment that can influence sourcing, manufacturing, and distribution decisions. Taken together, these dynamics are creating both opportunity and risk: the capacity to deliver differentiated patient outcomes at scale, and the exposure to supply chain disruption, cyber threats, and reimbursement uncertainty. This introduction sets the stage for an integrated analysis that follows, revealing the strategic inflection points organizations must address to capture long-term value from connected medical devices.

How accelerated software maturity, advanced connectivity standards, and shifting reimbursement models are redefining competitive advantage and regulatory obligations

The connected medical device landscape is undergoing a series of transformative shifts that are redefining competitive advantage, regulatory expectations, and care delivery models. First, the maturity curve of embedded software and AI-driven analytics has moved from prototype experimentation to clinically actionable features, prompting manufacturers to adopt lifecycle approaches to software validation, post-market performance monitoring, and algorithm governance. Consequently, product roadmaps now integrate clinical evidence generation and explainability as core commercial requirements rather than optional capabilities.

Second, the proliferation of low-power wide-area networks and higher-throughput cellular standards is expanding the feasible envelope for remote monitoring and telehealth integration. This connectivity evolution is enabling devices to operate in distributed care models with lower latency, richer telemetry, and greater reliability than prior generations. It also elevates the importance of interoperability-both syntactic and semantic-so that patient data can be aggregated, normalized, and acted upon across disparate health IT systems.

Third, reimbursement and procurement practices are gradually adapting to value-based paradigms, creating incentives for devices that demonstrably reduce acute care utilization and improve chronic disease outcomes. In parallel, regulatory authorities are refining guidance on software as a medical device, cybersecurity risk management, and real-world performance evidence, compelling manufacturers to embed regulatory strategy into product development cycles.

Finally, market structure is shifting as strategic partnerships between device makers, cloud providers, and clinical networks proliferate. These alliances accelerate market access but also introduce new dependencies and shared liabilities. The net effect of these shifts is a competitive landscape where agility in clinical validation, connectivity integration, and post-market stewardship distinguishes market leaders from laggards.

Operational and strategic consequences of tariff measures on sourcing, product design, and supply chain resilience for connected medical device stakeholders

Recent trade measures targeting medical device inputs and finished goods have introduced a complex set of cost, sourcing, and scheduling pressures for manufacturers and suppliers. Tariff actions, coupled with reciprocal trade responses, have changed the calculus for where components and assemblies are produced, prompting firms to reassess supplier portfolios, increase inventory buffers, and accelerate nearshoring or dual-sourcing strategies. These adjustments have downstream effects on lead times, quality control processes, and capital allocation for manufacturing upgrades.

Operationally, increased duties on specific components raise the effective landed cost of devices and can compress margins unless offset by pricing adjustments, supplier cost reductions, or moves to alternative materials. In many cases, manufacturers facing tariff exposure have pursued redesigns that substitute tariffed parts with functionally equivalent alternatives sourced from different jurisdictions. Such redesigns often entail qualification testing and updated regulatory submissions, creating timelines that extend beyond immediate commercial cycles.

Strategic responses to the tariff environment are varied. Some organizations elect to consolidate higher-value assembly within tariff-favored jurisdictions, while others build in pricing elasticity through service contracts and managed care arrangements that shift part of the cost burden. At the same time, procurement teams emphasize contract language that preserves renegotiation rights in the face of tariff escalations and encourage longer-term supply agreements to secure capacity.

Importantly, tariffs also influence innovation pathways. When component costs rise, development priorities may pivot toward higher-margin devices, software-enabled service layers, or aftermarket consumables that are less exposed to cross-border duties. Meanwhile, policy uncertainty surrounding trade measures increases the value of scenario planning and stress-testing for product portfolios, ensuring firms can preserve operational continuity and market access under alternative tariff trajectories.

In-depth segmentation analysis linking product subclasses, clinical applications, end-user environments, connectivity modalities, and distribution channels to adoption levers

Granular segmentation reveals how product design, clinical application, end-user contexts, connectivity choices, and distribution strategies shape adoption dynamics and commercial priorities. When viewed through Product Type lenses such as Diagnostic Devices, Monitoring Devices, Surgical Devices, Therapeutic Devices, and Wearable Devices, the nuanced needs of clinicians and patients emerge. Diagnostic Devices-and specifically imaging systems, point-of-care test kits, and ultrasound devices-demand high diagnostic accuracy, robust calibration workflows, and interoperability with picture archiving and communication systems. Monitoring Devices such as ECG monitors, glucose monitors, and vital signs monitors prioritize continuous data integrity, power management, and alarm management to support clinical decision-making. Surgical Devices, including electrosurgical devices, endoscopic devices, and robotic surgery systems, require exacting reliability, sterile compatibility, and seamless integration with operating room informatics. Therapeutic Devices like dialysis systems, infusion pumps, and ventilators emphasize safety redundancies, dose delivery accuracy, and fail-safe mechanisms. Wearable Devices, represented by fitness trackers and smart watches, balance consumer ergonomics, sensor fidelity, and seamless mobile connectivity to encourage sustained engagement.

Application-based segmentation further clarifies value propositions across drug delivery, imaging, patient monitoring, rehabilitation, surgical assistance, and telehealth. Within drug delivery, distinctions among infusion drug delivery, inhalation systems, and injection drug delivery influence device form factor, adherence monitoring, and connectivity to electronic medication records. Imaging modalities such as CT, MRI, ultrasound imaging, and X-ray carry distinct regulatory pathways, capital intensity, and clinician training requirements. Patient monitoring spans ambulatory monitoring, critical care monitoring, and remote monitoring, each with different signal-capture priorities, latency tolerances, and integration needs with clinical workflows. Rehabilitation applications from neurorehabilitation to occupational therapy and physical therapy leverage sensors and feedback loops to quantify outcomes and support remote care. Surgical assistance via navigation systems and robotic assistance underscores the convergence of precision mechanics, real-time imaging, and surgeon interface design. Telehealth subsegments-remote diagnosis, remote patient monitoring, and video consultation-highlight the need for seamless, secure data exchange and clear escalation pathways.

End-user segmentation across ambulatory care centers, clinics, diagnostic centers, home care settings, and hospitals shapes procurement cycles and support requirements. Home care settings, which include elderly care and post-operative care, prioritize ease of use, caregiver support, and remote clinician oversight. Hospitals, whether private or public, demand scale, service-level agreements, and evidence of clinical and economic benefit to support capital investments. Connectivity Technology choices-Bluetooth (including BLE and Classic Bluetooth), cellular standards spanning 2G through 5G, NFC, Wi-Fi (802.11ac and 802.11n), and Zigbee-determine device interoperability, power consumption, range, and security architecture. Finally, Distribution Channel differentiation between offline and online pathways influences customer experience, installation services, and aftermarket support, with online channels accelerating initial procurement but offline channels often remaining critical for complex device installation and training.

Regional considerations that shape commercialization, regulatory strategy, and supply chain choices across the Americas, Europe Middle East Africa, and Asia Pacific markets

Regional dynamics materially influence demand drivers, regulatory requirements, and go-to-market execution for connected medical devices. In the Americas, mature reimbursement landscapes, advanced hospital infrastructure, and a strong appetite for remote monitoring combine to favor devices that demonstrate clear value in reducing acute care utilization. The region also features a dense network of private and public payers, which can accelerate adoption of devices that align with chronic disease management and post-acute care pathways. Meanwhile, supply chain logistics and proximity to component suppliers make the Americas a focal point for nearshoring and rapid product iterations.

Europe, Middle East & Africa present a heterogeneous environment where regulatory harmonization efforts coexist with divergent procurement models. In many European markets, centralized purchasing and health technology assessment processes require robust clinical and economic evidence, while Middle Eastern and African markets may present high-growth pockets driven by private hospital expansion and investment in digital health infrastructure. Across this region, data protection standards and interoperability initiatives influence device design and cloud architecture decisions, necessitating adaptable regulatory strategies and localized support models.

Asia-Pacific exhibits a broad spectrum of maturity, from advanced markets with strong domestic manufacturing ecosystems to rapidly developing healthcare systems that leapfrog legacy infrastructure through digital-first deployments. The region's scale and diversity create opportunities for scalable, lower-cost device variants and modular platforms that can be customized to local clinical needs. Additionally, the availability of contract manufacturers and electronics suppliers supports cost optimization strategies, while evolving reimbursement frameworks and large patient populations present fertile ground for remote monitoring and telehealth solutions. Taken together, regional insights underscore the need for differentiated commercialization strategies that align evidence generation, supply chain design, and partnership ecosystems to local market realities.

Analysis of incumbent and challenger company strategies highlighting platformization, partnerships, and evidence-driven commercialization to scale connected device offerings

Leading companies in the connected medical device arena demonstrate consistent patterns: integration of software and services into their core offerings, prioritization of cybersecurity and regulatory compliance, and cultivation of ecosystem partnerships to extend clinical reach. Market leaders invest in modular platforms that enable rapid feature deployment and third-party integrations, while maintaining rigorous change-management processes for software updates and post-market surveillance. Their R&D approaches emphasize clinical collaboration, pilot deployments with health systems, and iterative validation to build clinician trust and reimbursement pathways.

Smaller and mid-sized firms often compete by focusing on niche clinical problems, leveraging agility to iterate user interfaces and accelerate time-to-market. These organizations commonly pursue partnerships with cloud and analytics providers to supplement internal capabilities, and they target partnerships with channel distributors or health systems to secure initial scale. Many such firms adopt hybrid business models that combine device sales with recurring revenue from analytics subscriptions, remote monitoring services, or consumable components.

Across the competitive landscape, there is a growing trend of strategic alliances between traditional device manufacturers and digital health specialists. These collaborations accelerate access to data science capabilities, patient engagement tools, and population health platforms. At the same time, cross-industry entrants emphasize speed and experience design but must rapidly develop clinical validation processes and regulatory expertise to compete sustainably. Collectively, these company-level behaviors reveal a competitive imperative: integrate clinical evidence, robust cybersecurity, and partnership-driven distribution to scale effectively in complex care environments.

Practical strategic moves for manufacturers and providers to fortify product development, supply chain resilience, and go-to-market models for connected devices

Industry leaders should adopt a three-pronged approach that aligns product strategy, operational resilience, and market engagement to capture long-term value from connected medical devices. First, embed regulatory and clinical evidence planning at the earliest stages of product development so that software iterations, algorithm updates, and hardware revisions proceed with minimal downstream friction. Proactive planning reduces time to market for new capabilities and strengthens payor dialogues when outcomes data becomes available.

Second, redesign supply chain and sourcing strategies to increase resilience against trade disruptions and tariff-induced cost pressures. This includes diversifying component suppliers, qualifying alternate materials where feasible, and evaluating nearshoring for critical assemblies. Simultaneously, align procurement contracts to include flexibility clauses for tariff pass-throughs and establish strategic inventory buffers for key components that face volatile trade exposure.

Third, prioritize interoperability, cybersecurity, and user-centered design to accelerate adoption across care settings. Invest in open APIs, standards-based data models, and rigorous penetration testing, while conducting clinician-centered usability studies that minimize training burdens. In parallel, develop commercial models that blend capital equipment sales with subscription services, enabling predictable revenue while offering customers lower upfront costs.

Finally, cultivate strategic partnerships with payors, health systems, and technology providers to co-develop reimbursement pathways and integrated care programs. Use pilot deployments to gather real-world evidence that supports reimbursement negotiations and expands clinical indications. Executed together, these recommendations position organizations to reduce operational risk, enhance product-market fit, and convert connected device capabilities into durable commercial advantage.

Transparent research approach combining stakeholder interviews, technical assessments, regulatory reviews, and scenario testing to validate connected device insights

The research synthesis underpinning this analysis integrates primary stakeholder interviews, technical product assessments, policy and regulatory reviews, and secondary literature synthesis to produce a holistic view of the connected medical device landscape. Primary inputs included structured interviews with clinicians, procurement officers, regulatory specialists, and device engineers to ground insights in operational realities and evidence needs. These conversations were complemented by technical assessments of representative device architectures, connectivity stacks, and cybersecurity postures to surface recurring engineering constraints and integration patterns.

Regulatory and policy review processes examined current guidance on software as a medical device, cybersecurity requirements, and trade measures affecting medical technology supply chains. This review was paired with a comparative analysis of regional procurement mechanisms and reimbursement frameworks to assess how evidence thresholds and purchasing behaviors differ across markets. Secondary literature and public filings were analyzed to validate company strategies and to triangulate industry trends, while case studies of successful pilot deployments were used to illustrate pathways to scale.

Analytical methodologies combined qualitative thematic coding with scenario-based stress testing to evaluate sensitivity to tariff changes, connectivity shifts, and regulatory updates. Where applicable, evidence hierarchies were applied to weigh clinical studies, pilot outcomes, and real-world performance data. Throughout, transparency in assumptions and source provenance was maintained to enable reproducibility and to support client follow-up questions for deeper dives into specific product or regional nuances.

Concluding perspective on the systemic requirements for translating connected medical device innovation into durable clinical value and commercial success

Connected medical devices represent a pivotal frontier in healthcare transformation, offering pathways to earlier diagnosis, continuous chronic disease management, and more efficient use of clinical capacity. The confluence of advanced sensing, embedded software, and pervasive connectivity has created new expectations for product design, evidence generation, and post-market stewardship. Organizations that synchronize clinical validation, cybersecurity, and interoperability with resilient supply chains will be better positioned to scale and sustain market advantage.

Yet the path forward is complex. Tariff actions and trade uncertainty compel firms to reassess sourcing strategies and cost structures, while evolving regulatory and reimbursement landscapes require disciplined evidence planning. Market leaders are responding by platformizing offerings, forging strategic partnerships, and investing in real-world performance evidence that supports clinician adoption and payer coverage. Success will hinge on an integrated approach that aligns product development, operations, and go-to-market execution around measurable clinical and economic outcomes.

In closing, the institutions that treat connected devices as systems-where hardware, software, clinical workflows, and commercial models are co-designed-will unlock the greatest value. Those that apply rigorous risk management to supply chains and regulatory pathways, while maintaining a relentless focus on user needs and data quality, will convert technological promise into sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of end-to-end encryption protocols for connected medical devices to strengthen cybersecurity
  • 5.2. Integration of artificial intelligence algorithms for real-time analysis of patient-generated health data streams
  • 5.3. Adoption of standardized interoperability frameworks to enable seamless data exchange across healthcare platforms
  • 5.4. Deployment of edge computing architectures within medical devices to reduce latency and improve treatment responsiveness
  • 5.5. Development of battery optimization technologies to extend operational lifespan of wireless medical monitoring devices
  • 5.6. Incorporation of voice-activated control features and natural language processing in medical device interfaces to enhance accessibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Connected Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Systems
    • 8.1.2. Point Of Care Test Kits
    • 8.1.3. Ultrasound Devices
  • 8.2. Monitoring Devices
    • 8.2.1. ECG Monitor
    • 8.2.2. Glucose Monitor
    • 8.2.3. Vital Signs Monitor
  • 8.3. Surgical Devices
    • 8.3.1. Electrosurgical Devices
    • 8.3.2. Endoscopic Devices
    • 8.3.3. Robotic Surgery Systems
  • 8.4. Therapeutic Devices
    • 8.4.1. Dialysis Systems
    • 8.4.2. Infusion Pumps
    • 8.4.3. Ventilators
  • 8.5. Wearable Devices
    • 8.5.1. Fitness Trackers
    • 8.5.2. Smart Watches

9. Connected Medical Devices Market, by Application

  • 9.1. Drug Delivery
    • 9.1.1. Infusion Drug Delivery
    • 9.1.2. Inhalation Systems
    • 9.1.3. Injection Drug Delivery
  • 9.2. Imaging
    • 9.2.1. CT
    • 9.2.2. MRI
    • 9.2.3. Ultrasound Imaging
    • 9.2.4. X Ray
  • 9.3. Patient Monitoring
    • 9.3.1. Ambulatory Monitoring
    • 9.3.2. Critical Care Monitoring
    • 9.3.3. Remote Monitoring
  • 9.4. Rehabilitation
    • 9.4.1. Neurorehabilitation
    • 9.4.2. Occupational Therapy
    • 9.4.3. Physical Therapy
  • 9.5. Surgical Assistance
    • 9.5.1. Navigation Systems
    • 9.5.2. Robotic Assistance
  • 9.6. Telehealth
    • 9.6.1. Remote Diagnosis
    • 9.6.2. Remote Patient Monitoring
    • 9.6.3. Video Consultation

10. Connected Medical Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care Settings
    • 10.4.1. Elderly Care
    • 10.4.2. Post Operative Care
  • 10.5. Hospitals
    • 10.5.1. Private Hospitals
    • 10.5.2. Public Hospitals

11. Connected Medical Devices Market, by Connectivity Technology

  • 11.1. Bluetooth
    • 11.1.1. BLE
    • 11.1.2. Classic Bluetooth
  • 11.2. Cellular
    • 11.2.1. 2G 3G 4G
    • 11.2.2. 5G
  • 11.3. NFC
  • 11.4. Wi Fi
    • 11.4.1. 802 11ac
    • 11.4.2. 802 11n
  • 11.5. Zigbee

12. Connected Medical Devices Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Connected Medical Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Connected Medical Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Connected Medical Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke Philips N.V.
    • 16.3.2. General Electric Company
    • 16.3.3. Medtronic plc
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Johnson & Johnson
    • 16.3.6. Abbott Laboratories
    • 16.3.7. Boston Scientific Corporation
    • 16.3.8. Baxter International Inc.
    • 16.3.9. ResMed Inc.
    • 16.3.10. Dexcom, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CONNECTED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CONNECTED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONNECTED MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL CONNECTED MEDICAL DEVI